Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.
about
Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosisOral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)Pathophysiology of the antiphospholipid syndromeAntiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission.Attempts to make sense of the antiphospholipid syndrome.Antiphospholipids antibodies in a 12-month-old presenting with idiopathic thrombocytopenic purpura.Antiphospholipid antibodies: paradigm in transition.Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsElevated clotting factor levels and venous thrombosis.Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor.Pathogenic role of antiphospholipid antibodiesThe role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.Platelets and autoimmunity.Immunotherapeutic strategies in antiphospholipid syndrome.A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserine-exposing blood platelets.Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.The activated seven lupus anticoagulant assay detects clinically significant antibodies.Evaluation of platelet aggregation in the presence of antiphospholipid antibodies: anti-β2GP1 and anticardiolipin.Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2.Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.A patient with Hodgkin's lymphoma, antiphospholipid syndrome and severe mitral insufficiency.Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
P2860
Q24816944-7329C2AD-A697-421A-A63D-CC0FCFFE635DQ28174743-C740FCE0-6050-4FF2-B6BA-4010151C03D3Q28174751-624B6FCB-C5D5-4F86-843B-C2A7AA71C498Q28267421-A5C949B2-A0EB-4052-9973-ADC041D4CB8AQ33364647-3032E0E1-9E29-450C-B868-D4FAD8F992CEQ33372890-76BCCC3E-0690-4E24-B3A8-572F01530AD8Q33379377-13C999AF-A279-47C1-9654-131E6B957DA7Q33382848-5B487BB2-F53A-45A9-B983-A18EA353587EQ35067429-5071A307-3361-4C4B-B027-E28F949450B5Q36030521-09151533-C62B-4643-8A86-01271986E005Q36174626-BA123556-2B5B-4A26-BDAF-BA49D913EFD2Q37168017-1049894C-8824-4830-85F7-F2C4FD1261D5Q37721602-6AF30B74-CCEB-4392-9387-213B7B5B17CBQ38101678-9543E3D0-B194-4038-AEFD-B93DD95BF546Q38826804-A407D7E6-AD19-4380-97A9-BFF2B79AB399Q40358418-D0CA4056-0057-4F69-B786-28184FDFCBB5Q42034633-FAC1F44E-ED06-41DF-BEAE-B421B2B21F0EQ42378451-A515DF14-AE8A-4559-89EA-532238A9539FQ45871506-BCFC87ED-D90E-4BE5-AE94-29954C49469CQ46562065-B70BFD8E-C7EF-4CEE-866B-FA14C3DC1D0FQ47698131-07C3CB6D-4AA9-4E96-9935-1AB35C612E63Q51104155-99E6F588-B687-440F-BD33-1AADDC57BC6CQ51777386-58192774-E6FB-4C53-B47B-65AA0CD68717Q51818187-D8DD8E51-275F-4679-9602-291287C9F0E7
P2860
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Current status and implication ...... elation to thrombotic disease.
@ast
Current status and implication ...... elation to thrombotic disease.
@en
type
label
Current status and implication ...... elation to thrombotic disease.
@ast
Current status and implication ...... elation to thrombotic disease.
@en
prefLabel
Current status and implication ...... elation to thrombotic disease.
@ast
Current status and implication ...... elation to thrombotic disease.
@en
P2860
P1476
Current status and implication ...... elation to thrombotic disease.
@en
P2093
P2860
P304
P356
10.1046/J.1538-7836.2003.00125.X
P577
2003-05-01T00:00:00Z